🇺🇸 FDA

Intelligence · Patent portfolio

Rani Therapeutics Holdings Patents

Full USPTO pharma patent portfolio for Rani Therapeutics Holdings — grant dates, expiration, and drug cross-links.

Patents
148
Expiring ≤24m
1

Quick answer

Rani Therapeutics Holdings has 148 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 4

  1. US 10548850

    Therapeutic composition comprising insulin prepared for delivery into an intestinal tract

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10493253

    Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10487145

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10478396

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10456373

    Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10377739

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10350163

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10335463

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10322167

    Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10314892

    Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10314891

    Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10307579

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10300010

    Methods for delivering entanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10252039

    Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10220029

    Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10196377

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10179228

    Swallowable drug delivery device and methods of drug delivery

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10155745

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10155747

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10155746

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10155743

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10155744

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10039908

    Swallowable drug delivery device and method of delivery

    Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10029080

    Method for delivering exenatide into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10004783

    Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10006080

    High-selectivity contact activation inhibitor based on infestin-4

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9999613

    2H-chromene derivatives as analgesic agents

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9956178

    Methods for delivering insulin preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9949962

    Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9907747

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9861683

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9844655

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9844505

    Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9820970

    Method and agent for the treatment and prophylaxis of diseases caused by (+)RNA-containing viruses

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9815814

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9808510

    Method for delivering gonadotropin releasing hormone into a lumen of the intestinal tract

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9757548

    Method for delivering a therapeutic agent into the wall of the small intestine

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9757514

    Device, system and methods for the oral delivery of therapeutic compounds

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9745337

    Complex compounds of germanium, methods for producing same, and drugs

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9730915

    Method for preventing or treating diseases associated with a reduced density of interferon receptors

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9629799

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9605013

    Derivatives of hemin with antibacterial and antiviral activity

    Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9597276

    Composition for the prophylaxis of candidiasis

    Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9546188

    Complexes of germanium with amino acids and carboxylic acids and method for preparing same

    Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9539207

    Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery

    Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9522910

    Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon

    Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9511121

    Method for delivering exenatide to a patient in need thereof

    Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9492378

    Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Rani Therapeutics Holdings have?

148 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Rani Therapeutics Holdings patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.